Registration number: 10304526

Fusion DNA Limited

Contents

Balance Sheet	1 to 2
Notes to the Financial Statements	3 to 8

Fusion DNA Limited

(Registration number: 10304526)
Balance Sheet as at 31 August 2025

	Note	2025 £		2024 £
Fixed assets
Intangible assets	4		150,000		300,000
Tangible assets	5		8,590		10,948
Investments			5		5
			158,595		310,953
Current assets
Debtors	6	710,827		843,211
Cash at bank and in hand		198,325		216,853
		909,152		1,060,064
Creditors: Amounts falling due within one year	7	(205,932)		(303,471)
Net current assets			703,220		756,593
Total assets less current liabilities			861,815		1,067,546
Provisions for liabilities			(1,420)		(1,850)
Net assets			860,395		1,065,696
Capital and reserves
Called up share capital	9	200		200
Retained earnings		860,195		1,065,496
Shareholders' funds			860,395		1,065,696

Fusion DNA Limited

(Registration number: 10304526)
Balance Sheet as at 31 August 2025

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 27 May 2026 and signed on its behalf by:
 

......................................... S Douglas Director

Fusion DNA Limited

Notes to the Financial Statements for the Year Ended 31 August 2025

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
4 Risborough Street
London
SE1 0HE

These financial statements were authorised for issue by the Board on 27 May 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' including the disclosure and presentation requirements of Section 1A and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company's functional and presentation currency is pound sterling.

Summary of disclosure exemptions

The company has taken advantage of the exemption under Financial Reporting Standard 102 Section 1AC.35 from disclosing transactions and balances with fellow group undertakings that are wholly owned.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax.

The company recognises revenue when the amount of revenue can be measured reliably and it is probable that future economic benefits will flow to the entity.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Fusion DNA Limited

Notes to the Financial Statements for the Year Ended 31 August 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Furniture, fittings and equipment	20% straight line
Office equipment	33% straight line

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	10% straight line

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Fusion DNA Limited

Notes to the Financial Statements for the Year Ended 31 August 2025

Financial instruments

Financial assets

Basic financial assets, including trade and other receivables, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar asset. Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss and any subsequent reversal is recognised in profit or loss.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.
 

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 13 (2024 - 14).

Fusion DNA Limited

Notes to the Financial Statements for the Year Ended 31 August 2025

4	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 1 September 2024	1,500,000	1,500,000
At 31 August 2025	1,500,000	1,500,000
Amortisation
At 1 September 2024	1,200,000	1,200,000
Amortisation charge	150,000	150,000
At 31 August 2025	1,350,000	1,350,000
Carrying amount
At 31 August 2025	150,000	150,000
At 31 August 2024	300,000	300,000

5	Tangible assets

	Furniture, fittings and equipment  £	Office equipment £	Total £
Cost or valuation
At 1 September 2024	1,743	55,422	57,165
Additions	-	4,841	4,841
Disposals	-	(28,199)	(28,199)
At 31 August 2025	1,743	32,064	33,807
Depreciation
At 1 September 2024	1,743	44,474	46,217
Charge for the year	-	7,199	7,199
Eliminated on disposal	-	(28,199)	(28,199)
At 31 August 2025	1,743	23,474	25,217
Carrying amount
At 31 August 2025	-	8,590	8,590
At 31 August 2024	-	10,948	10,948

Fusion DNA Limited

Notes to the Financial Statements for the Year Ended 31 August 2025

6

Debtors

	2025 £	2024 £
Trade debtors	265,672	351,916
Amounts owed by group undertakings	1,000	1,000
Prepayments	52,112	73,444
Other debtors	392,043	416,851
	710,827	843,211

7

Creditors

Creditors: amounts falling due within one year

	Note	2025 £	2024 £
Due within one year
Loans and borrowings	8	-	45,833
Trade creditors		3,472	6,946
Taxation and social security		172,526	191,981
Accruals and deferred income		12,443	38,675
Other creditors		17,491	20,036
		205,932	303,471